Cargando…
Piezo1 activates noncanonical EGFR endocytosis and signaling
EGFR-ERK signaling controls cell cycle progression during development, homeostasis, and disease. While EGF ligand and mechanical inputs can activate EGFR-ERK signaling, the molecules linking mechanical force to this axis have remained mysterious. We previously found that stretch promotes mitosis via...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530101/ https://www.ncbi.nlm.nih.gov/pubmed/37756411 http://dx.doi.org/10.1126/sciadv.adi1328 |
_version_ | 1785111470863810560 |
---|---|
author | Pardo-Pastor, Carlos Rosenblatt, Jody |
author_facet | Pardo-Pastor, Carlos Rosenblatt, Jody |
author_sort | Pardo-Pastor, Carlos |
collection | PubMed |
description | EGFR-ERK signaling controls cell cycle progression during development, homeostasis, and disease. While EGF ligand and mechanical inputs can activate EGFR-ERK signaling, the molecules linking mechanical force to this axis have remained mysterious. We previously found that stretch promotes mitosis via the stretch-activated ion channel Piezo1 and ERK signaling. Here, we show that Piezo1 provides the missing link between mechanical signals and EGFR-ERK activation. While both EGF- and Piezo1-dependent activation trigger clathrin-mediated EGFR endocytosis and ERK activation, EGF relies on canonical tyrosine autophosphorylation, whereas Piezo1 involves Src-p38 kinase-dependent serine phosphorylation. In addition, unlike EGF, ex vivo lung slices treated with Piezo1 agonist promoted cell cycle re-entry via nuclear ERK, AP-1 (FOS and JUN), and YAP accumulation, typical of regenerative and malignant signaling. Our results suggest that mechanical activation via Piezo1, Src, and p38 may be more relevant to controlling repair, regeneration, and cancer growth than tyrosine kinase signaling via canonical EGF signaling, suggesting an alternative therapeutic approach. |
format | Online Article Text |
id | pubmed-10530101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-105301012023-09-28 Piezo1 activates noncanonical EGFR endocytosis and signaling Pardo-Pastor, Carlos Rosenblatt, Jody Sci Adv Biomedicine and Life Sciences EGFR-ERK signaling controls cell cycle progression during development, homeostasis, and disease. While EGF ligand and mechanical inputs can activate EGFR-ERK signaling, the molecules linking mechanical force to this axis have remained mysterious. We previously found that stretch promotes mitosis via the stretch-activated ion channel Piezo1 and ERK signaling. Here, we show that Piezo1 provides the missing link between mechanical signals and EGFR-ERK activation. While both EGF- and Piezo1-dependent activation trigger clathrin-mediated EGFR endocytosis and ERK activation, EGF relies on canonical tyrosine autophosphorylation, whereas Piezo1 involves Src-p38 kinase-dependent serine phosphorylation. In addition, unlike EGF, ex vivo lung slices treated with Piezo1 agonist promoted cell cycle re-entry via nuclear ERK, AP-1 (FOS and JUN), and YAP accumulation, typical of regenerative and malignant signaling. Our results suggest that mechanical activation via Piezo1, Src, and p38 may be more relevant to controlling repair, regeneration, and cancer growth than tyrosine kinase signaling via canonical EGF signaling, suggesting an alternative therapeutic approach. American Association for the Advancement of Science 2023-09-27 /pmc/articles/PMC10530101/ /pubmed/37756411 http://dx.doi.org/10.1126/sciadv.adi1328 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Pardo-Pastor, Carlos Rosenblatt, Jody Piezo1 activates noncanonical EGFR endocytosis and signaling |
title | Piezo1 activates noncanonical EGFR endocytosis and signaling |
title_full | Piezo1 activates noncanonical EGFR endocytosis and signaling |
title_fullStr | Piezo1 activates noncanonical EGFR endocytosis and signaling |
title_full_unstemmed | Piezo1 activates noncanonical EGFR endocytosis and signaling |
title_short | Piezo1 activates noncanonical EGFR endocytosis and signaling |
title_sort | piezo1 activates noncanonical egfr endocytosis and signaling |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530101/ https://www.ncbi.nlm.nih.gov/pubmed/37756411 http://dx.doi.org/10.1126/sciadv.adi1328 |
work_keys_str_mv | AT pardopastorcarlos piezo1activatesnoncanonicalegfrendocytosisandsignaling AT rosenblattjody piezo1activatesnoncanonicalegfrendocytosisandsignaling |